tolvaptan has been researched along with Pulmonary Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Q; Li, Y; Luo, H | 1 |
| Fukada, Y; Hirota, M; Hoshino, J; Isomura, T; Kondo, T; Takahashi, Y | 1 |
| Fukuda, K; Humbert, M; Kimura, M; Kuwana, M; Ono, T; Satoh, T; Takei, M; Tamura, Y | 1 |
3 other study(ies) available for tolvaptan and Pulmonary Hypertension
| Article | Year |
|---|---|
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Topics: Bilirubin; China; Diuretics; Humans; Hypertension, Pulmonary; Retrospective Studies; Tolvaptan; Uric Acid | 2022 |
[Effectiveness of tolvaptan for postoperative heart failure in a patient with combined valvular disease and pulmonary hypertension].
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Failure; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Male; Middle Aged; Postoperative Complications; Tolvaptan | 2014 |
Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension.
Topics: Administration, Oral; Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Drug Administration Schedule; Female; Furosemide; Heart Failure; Humans; Hypertension, Pulmonary; Male; Middle Aged; Outpatients; Prospective Studies; Tolvaptan; Treatment Outcome | 2015 |